TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19370038

Group type: EXPERIMENTAL
Intervention: Flaxseed lignan complex (543 mg/day in a 4050 mg complex)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flaxseed lignan complex
Number of subjects: 100
Study: 16425426

Group type: EXPERIMENTAL
Intervention: H pylori eradication therapy
Number of subjects: 259

Group type: COMPARATOR
Intervention: Untreated group (H pylori-infected)
Number of subjects: 259
Study: 12860938

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 and cisplatin 75 mg/m2
Number of subjects: 456

Group type: COMPARATOR
Intervention: Cisplatin 75 mg/m2
Number of subjects: 456
Study: 10670374

Group type: EXPERIMENTAL
Intervention: Self-instructional module (SIM) on care of child receiving Oxygen Therapy
Number of subjects: 30
Study: 2568663

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Minor tranquilizer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mental arithmetic (stressor)
Number of subjects: 40
Study: 358760

Group type: EXPERIMENTAL
Intervention: Pindolol once daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Pindolol twice daily
Number of subjects: 21
Study: 30558051

Group type: EXPERIMENTAL
Intervention: Health education by Wechat platform plus usual care
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 27498443

Group type: EXPERIMENTAL
Intervention: Combination of amoxicillin and metronidazole (for 7 days)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cefixime (for 7 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 90
Study: 25813770

Group type: EXPERIMENTAL
Intervention: Home implantable hemodynamic monitor (IHM) data
Number of subjects: 537
Study: 22948012

Group type: EXPERIMENTAL
Intervention: 12-month exercise training (n=11)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control period (n=10)
Number of subjects: 33
Study: 20558433

Group type: EXPERIMENTAL
Intervention: DVD-based educational intervention
Number of subjects: 25
Study: 17900989

Group type: EXPERIMENTAL
Intervention: Exercise training (a combination of aerobic and resistance training, three times per week for 24 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no formal exercise program during the 24-week intervention)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 21
Study: 15721028

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 14587010

Group type: EXPERIMENTAL
Intervention: Blood-pool contrast media (NC100150, 2 ml/kg body weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional X-ray venography (XRV)
Number of subjects: 12
Study: 10475476

Group type: EXPERIMENTAL
Intervention: Ventricular assist devices (VADs)
Number of subjects: 19
Study: 8708369

Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine (300 mg/4 weeks)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Orally trimethoprim‐sulfamethoxazole (320‐1600 mg/day)
Number of subjects: 220
Study: 1752294

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg three times a day (t.d.s.)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg three times a day (t.d.s.) with dipyridamole 100 mg t.d.s.
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Liquid crystal thermography
Number of subjects: 112
Study: 7235320

Group type: EXPERIMENTAL
Intervention: Flunisolide intranasal solution (200 microgram/day) combined with intrabronchial flunisolide (1 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Flunisolide intranasal solution (200 microgram/day) combined with beclomethasone dipropionate bronchial aerosol (400 microgram/day)
Number of subjects: 17
Study: 31503037

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (posttetanic count 1 to 2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Moderate neuromuscular block (train-of-four count 1 to 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Moderate neuromuscular block
Number of subjects: 100
Study: 28494850

Group type: EXPERIMENTAL
Intervention: Traditional Persian medicine preparation of Alcea digitata and Malva sylvestris
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypozalix (artificial saliva)
Number of subjects: 0
Study: 26388532

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-alcohol
Number of subjects: 2546

Group type: COMPARATOR
Intervention: Povidone iodine-alcohol
Number of subjects: 2546
Study: 23512915

Group type: EXPERIMENTAL
Intervention: IVR (Interactive Voice Technology)
Number of subjects: 50

Group type: COMPARATOR
Intervention: WLC (Wait-List Control)
Number of subjects: 50
Study: 22092904

Group type: EXPERIMENTAL
Intervention: BEEM rater scale (n = 68)
Number of subjects: 134

Group type: COMPARATOR
Intervention: McMaster Online Rating of Evidence (MORE) scale (n = 66)
Number of subjects: 134
Study: 19232883

Group type: EXPERIMENTAL
Intervention: Recruitment manoeuvre (RM) followed by a 10 cmH(2)O positive end expiratory pressure (PEEP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: 10 cmH(2)O positive end expiratory pressure (PEEP)
Number of subjects: 26
Study: 17467203

Group type: EXPERIMENTAL
Intervention: E2/DRSP (estradiol 1 mg/drospirenone 2 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 14702836

Group type: EXPERIMENTAL
Intervention: Specific antivenom
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard antivenom
Number of subjects: 74
Study: 11105934

Group type: EXPERIMENTAL
Intervention: lorazepam
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: diazepam
Number of subjects: 3

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 3
Study: 10167210

Group type: EXPERIMENTAL
Intervention: Electronic academic detailer intervention with expert prescribing-system software for physicians.
Number of subjects: 16000
Study: 8093363

Group type: EXPERIMENTAL
Intervention: d4T (2 mg/kg/day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: d4T
Number of subjects: 41
Study: 3531862

Group type: EXPERIMENTAL
Intervention: Continuous intravenous heparin
Number of subjects: 115

Group type: COMPARATOR
Intervention: Intermittent subcutaneous heparin
Number of subjects: 115
Study: 30280654

Group type: EXPERIMENTAL
Intervention: Wearable cardioverter-defibrillator plus guideline-directed therapy
Number of subjects: 2302

Group type: COMPARATOR
Intervention: Guideline-directed therapy only (control group)
Number of subjects: 2302
Study: 26663817

Group type: EXPERIMENTAL
Intervention: DHEA (25 mg three times a day for 12 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 25591511

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional medicinal treatment
Number of subjects: 40
Study: 22460067

Group type: EXPERIMENTAL
Intervention: Ultrarush initiation (3 visits over 2 weeks)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Semirush initiation (10 visits over 9 weeks)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Maintenance dose of 50 μg
Number of subjects: 213

Group type: COMPARATOR
Intervention: Maintenance dose of 100 μg
Number of subjects: 213
Study: 20091327

Group type: EXPERIMENTAL
Intervention: Lightweight mesh (LW)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Heavyweight mesh (HW)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Lightweight mesh (LW) and Heavyweight mesh (HW)
Number of subjects: 135
Study: 18174779

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker-based program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker-based treatment regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple-drug therapy (therapy with > or =2 medications)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 0
Study: 15954250

Group type: EXPERIMENTAL
Intervention: Teflon-coated sonic scaler insert (tSS)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Conventional sonic scaler (SS)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Gracey curette
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Piezoelectric ultrasonic scaler insert (US)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Oscillating Periotor insert (PT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Untreated site
Number of subjects: 82
Study: 12872679

Group type: EXPERIMENTAL
Intervention: Cetirizine (daily treatment for 3 years)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (daily treatment for 3 years)
Number of subjects: 20
Study: 10567781

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg once daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 7587910

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid ethyl (EPA-E) 900 mg/day
Number of subjects: 0
Study: 2082783

Group type: EXPERIMENTAL
Intervention: Duxil
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 120541

Group type: COMPARATOR
Intervention: Alcohol (1 g/kg in orange juice)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alcohol (1 g/kg in orange juice) plus CBD (200 mg capsule)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CBD (200 mg capsule)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (glucose capsule and orange juice)
Number of subjects: 10
Study: 31184996

Group type: EXPERIMENTAL
Intervention: Hydrocellular foam dressing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hydrocolloid plate dressing
Number of subjects: 80
Study: 29455384

Group type: EXPERIMENTAL
Intervention: Mindful Moms Training (MMT)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Emotional Brain Training (EBT)
Number of subjects: 46
Study: 26872000

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT)
Number of subjects: 72
Study: 25317090

Group type: EXPERIMENTAL
Intervention: Gabapentin 500 mg
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Gabapentin 250 mg
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 377
Study: 22679719

Group type: EXPERIMENTAL
Intervention: Shencao Tongmai Granule (STG) plus Western medicine (WM) treatment
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo plus Western medicine (WM) treatment
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 280
Study: 20599196

Group type: EXPERIMENTAL
Intervention: Sustained uterine massage
Number of subjects: 1964

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 1964

Group type: COMPARATOR
Intervention: Oxytocin plus sustained uterine massage
Number of subjects: 1964
Study: 17670757

Group type: EXPERIMENTAL
Intervention: Sorin Freedom stentless valve
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sorin More stented valve
Number of subjects: 60
Study: 15918119

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0
Study: 12076231

Group type: EXPERIMENTAL
Intervention: Aerobic exercise only
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Weight management program that included exercise
Number of subjects: 82

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 82
Study: 9809893

Group type: EXPERIMENTAL
Intervention: Bivalirudin (direct thrombin inhibitor)
Number of subjects: 17000

Group type: COMPARATOR
Intervention: Intravenous heparin
Number of subjects: 17000
Study: 7714265

Group type: EXPERIMENTAL
Intervention: Random Amplitude Modulation (RAM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sinusoidal Amplitude Modulation (SAM)
Number of subjects: 0
Study: 2490827

Group type: EXPERIMENTAL
Intervention: Drug treatment for hypertension (including thiazide-like diuretic agents)
Number of subjects: 43000

Group type: COMPARATOR
Intervention: Drug treatment for hypertension
Number of subjects: 43000
Study: 946209

Group type: EXPERIMENTAL
Intervention: Rabies vaccine produced in human diploid cell culture (WI-38)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Rabies vaccine produced in hamster kidney-cell culture
Number of subjects: 31
Study: 7377574

Group type: EXPERIMENTAL
Intervention: Naloxone, 8 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Naloxone, 4 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 21
Study: 31882012

Group type: EXPERIMENTAL
Intervention: Usual Care Plus LEF-SCP
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Usual Care Plus LEF-SCP Plus Follow-Up
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 75
Study: 30210819

Group type: EXPERIMENTAL
Intervention: ID93 + GLA-SE
Number of subjects: 60

Group type: COMPARATOR
Intervention: ID93 alone
Number of subjects: 60
Study: 26733360

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment for Insomnia (CBT-I) followed by Positive Airway Pressure (PAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment for Insomnia (CBT-I) and Positive Airway Pressure (PAP) administered concurrently
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive Airway Pressure (PAP) alone
Number of subjects: 0
Study: 24742739

Group type: EXPERIMENTAL
Intervention: Everolimus (5 mg/day) plus trastuzumab (2 mg/kg) and vinorelbine (25 mg/m(2))
Number of subjects: 569

Group type: COMPARATOR
Intervention: Placebo plus trastuzumab and vinorelbine
Number of subjects: 569
Study: 22431673

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 2.5 mg
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 808

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 808
Study: 20232280

Group type: EXPERIMENTAL
Intervention: Digoxin immune Fab (DIF)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 17924890

Group type: EXPERIMENTAL
Intervention: Peribulbar block
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Topical lidocaine 2% combined with general anaesthesia
Number of subjects: 45

Group type: COMPARATOR
Intervention: General anaesthesia alone
Number of subjects: 45
Study: 16305009

Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide whitening strips (Crest Whitestrips Premium)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 6% hydrogen peroxide whitening strips (Crest Whitestrips)
Number of subjects: 40
Study: 11909936

Group type: EXPERIMENTAL
Intervention: Pain-promoting interaction
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pain-reducing interaction
Number of subjects: 120

Group type: COMPARATOR
Intervention: No training control group
Number of subjects: 120
Study: 9568921

Group type: EXPERIMENTAL
Intervention: First trimester alcohol use
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Tobacco use during each of the three trimesters
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Third trimester marijuana use
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: First trimester other illicit drug use
Number of subjects: 74
Study: 8549258

Group type: EXPERIMENTAL
Intervention: Multisession educational program about the care of residents with diabetes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (nursing staffs from two other similar facilities who did not participate in the educational program)
Number of subjects: 0
Study: 2197635

Group type: EXPERIMENTAL
Intervention: 3 x 1 g xantinolnicotinate (Complamin)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 320808

Group type: EXPERIMENTAL
Intervention: 3 mg/kg of 2% plain prilocaine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3 mg/kg of 2% plain mepivacaine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 10
Study: 29696736

Group type: EXPERIMENTAL
Intervention: BECM group (bismuth added)
Number of subjects: 66

Group type: COMPARATOR
Intervention: ECM group (no bismuth)
Number of subjects: 66
Study: 27905522

Group type: EXPERIMENTAL
Intervention: 6-month resistance exercise training with dietary intervention
Number of subjects: 101

Group type: COMPARATOR
Intervention: 6-month resistance exercise training without dietary intervention
Number of subjects: 101
Study: 24694553

Group type: EXPERIMENTAL
Intervention: 3D navigation
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 2D navigation
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional fluoroscopy
Number of subjects: 130
Study: 22634969

Group type: EXPERIMENTAL
Intervention: SHORT warm-up (30 minutes lower intensity)
Number of subjects: 14

Group type: COMPARATOR
Intervention: LONG warm-up (traditional warm-up)
Number of subjects: 14

Group type: COMPARATOR
Intervention: LONG warm-up
Number of subjects: 14
Study: 20458108

Group type: EXPERIMENTAL
Intervention: Visits to family physicians
Number of subjects: 4999

Group type: COMPARATOR
Intervention: Visits to pediatricians
Number of subjects: 4999
Study: 18312708

Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 239

Group type: COMPARATOR
Intervention: Scissors
Number of subjects: 239
Study: 15717255

Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 468

Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 468
Study: 12843161

Group type: EXPERIMENTAL
Intervention: Testosterone (200 mg mixed esters)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (200 mg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 10983343

Group type: EXPERIMENTAL
Intervention: Oxytocin (parenteral administration)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oxytocin (intra-arterial or local use)
Number of subjects: 90
Study: 8738539

Group type: EXPERIMENTAL
Intervention: Surface-treated catheters (Spi-Argent n=14; Spi-Silicone n=16)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Untreated catheters
Number of subjects: 56
Study: 1583340

Group type: EXPERIMENTAL
Intervention: Ivermectin (1 mg clearing dose followed by either one or two 200 micrograms/kg doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (12 daily 6 mg/kg doses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Not applicable (comparison of IgG levels)
Number of subjects: 30
Study: 3905392

Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion (7.5 ng X kg‐1 X min‐1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline solution infusion (control)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Angiotensin II infusion
Number of subjects: 7
Study: 30597550

Group type: EXPERIMENTAL
Intervention: Parent-mediated treatment
Number of subjects: 42
Study: 29694316

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) + Treatment as Usual (TAU)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 101
Study: 26444907

Group type: EXPERIMENTAL
Intervention: Calcipotriene 0.005% and betamethasone dipropionate 0.064% aerosol foam
Number of subjects: 376

Group type: COMPARATOR
Intervention: Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment
Number of subjects: 376

Group type: COMPARATOR
Intervention: Aerosol foam vehicle
Number of subjects: 376

Group type: COMPARATOR
Intervention: Ointment vehicle
Number of subjects: 376
Study: 25045768

Group type: EXPERIMENTAL
Intervention: Conventional dentifrice (1072 mgF/kg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low-fluoride dentifrice (513 mgF/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (fluoride-free)
Number of subjects: 11
Study: 22488499

Group type: EXPERIMENTAL
Intervention: Physiotherapist-guided pelvic floor muscle exercises (PG-PFME)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Folder-based pelvic floor muscle exercises (F-PFME)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Preoperative detrusor overactivity (DOA)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Preoperative urodynamic parameters
Number of subjects: 66
Study: 20130406

Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis (EFA)
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis (CFA)
Number of subjects: 778
Study: 18499730

Group type: EXPERIMENTAL
Intervention: Acute intra-arterial vitamin C administration (24 mg min(‐1))
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Chronic oral vitamin C supplementation (500 mg day(‐1))
Number of subjects: 33
Study: 15949096

Group type: EXPERIMENTAL
Intervention: 2 per cent lignocaine
Number of subjects: 58

Group type: COMPARATOR
Intervention: 0.9 per cent saline
Number of subjects: 58
Study: 12915645

Group type: EXPERIMENTAL
Intervention: Biphasic association of 40/30 micro g ethinyl estradiol (EE) and 25/125 micro g desogestrel (DSG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Monophasic association of 35 micro g EE and 2 mg cyproterone acetate (CPA)
Number of subjects: 20
Study: 14677619

Group type: EXPERIMENTAL
Intervention: GTD 60 microg/EE 15 microg for 24 days
Number of subjects: 27
Study: 8906382

Group type: EXPERIMENTAL
Intervention: Daily disposable contact lenses
Number of subjects: 338

Group type: COMPARATOR
Intervention: Conventional daily wear contact lenses
Number of subjects: 338

Group type: COMPARATOR
Intervention: Frequent replacement (1/3 months) contact lenses
Number of subjects: 338

Group type: COMPARATOR
Intervention: Frequent replacement (2-weeks) contact lenses
Number of subjects: 338
Study: 2052854

Group type: EXPERIMENTAL
Intervention: Ivermectin 100 mcg/kg
Number of subjects: 58

Group type: COMPARATOR
Intervention: DEC 3 mg/kg
Number of subjects: 58

Group type: COMPARATOR
Intervention: DEC 6 mg/kg
Number of subjects: 58
Study: 6191906

Group type: EXPERIMENTAL
Intervention: 1 g/day ISO for 7 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4 g/day ISO for 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment for 7 days
Number of subjects: 60
Study: 31977099

Group type: EXPERIMENTAL
Intervention: Ergonomics training utilizing photography (N=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (N=15)
Number of subjects: 30
Study: 30777112

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHAP) for a 3-day course
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community engagement and co-design of information messages
Number of subjects: 0